Matches in Wikidata for { <http://www.wikidata.org/entity/Q63405490> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q63405490 description "clinical trial" @default.
- Q63405490 description "ensayu clínicu" @default.
- Q63405490 description "klinisch onderzoek" @default.
- Q63405490 description "клінічне випробування" @default.
- Q63405490 name "Rituximab and Pembrolizumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma" @default.
- Q63405490 type Item @default.
- Q63405490 label "Rituximab and Pembrolizumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma" @default.
- Q63405490 prefLabel "Rituximab and Pembrolizumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma" @default.
- Q63405490 P1050 Q63405490-15C8B470-C865-47F6-AFC5-5D96B71A0E06 @default.
- Q63405490 P1132 Q63405490-32A3E70C-CDDE-42E8-9A94-3E5A02218FA3 @default.
- Q63405490 P1476 Q63405490-5158F8FB-B2B5-4376-A1A7-41361D2C78C4 @default.
- Q63405490 P17 Q63405490-78BDF09D-4DBE-48DB-B167-D3406F15FD93 @default.
- Q63405490 P2899 Q63405490-630B6410-3599-40EC-B645-93A17BCEFBF0 @default.
- Q63405490 P3098 Q63405490-47B9EBC1-0BD0-439E-B8ED-70C82870A71B @default.
- Q63405490 P31 Q63405490-61870578-3BDB-43DC-9D1A-8B5C9001AE56 @default.
- Q63405490 P4844 Q63405490-4FB58630-F3E8-44F1-980F-89DF1135526C @default.
- Q63405490 P4844 Q63405490-E11E2F36-27EB-4825-A17E-39172D36529F @default.
- Q63405490 P580 Q63405490-1A0618E8-589C-449A-AA79-B371E045E49F @default.
- Q63405490 P582 Q63405490-D7D18DA4-B3C8-434B-B327-937F6AB8AD99 @default.
- Q63405490 P6099 Q63405490-F17BFF06-9E2C-4C75-8213-B43AF1B481E8 @default.
- Q63405490 P6153 Q63405490-47F88E62-133B-475F-B6E2-D8C50B3B5C38 @default.
- Q63405490 P8363 Q63405490-0B403AD5-A053-4BE0-BB4E-078C8ADA78BE @default.
- Q63405490 P859 Q63405490-9C9F5A0D-EA22-4494-A16E-9EAB1E41D165 @default.
- Q63405490 P1050 Q208414 @default.
- Q63405490 P1132 "+37" @default.
- Q63405490 P1476 "Phase II Study of Rituximab Plus Pembrolizumab (MK-3475) in Subjects With Relapsed Follicular and Diffuse Large B-Cell Lymphoma" @default.
- Q63405490 P17 Q30 @default.
- Q63405490 P2899 "+18" @default.
- Q63405490 P3098 "NCT03401853" @default.
- Q63405490 P31 Q30612 @default.
- Q63405490 P4844 Q13896859 @default.
- Q63405490 P4844 Q412323 @default.
- Q63405490 P580 "2018-03-23T00:00:00Z" @default.
- Q63405490 P582 "2021-02-15T00:00:00Z" @default.
- Q63405490 P6099 Q42824440 @default.
- Q63405490 P6153 Q219563 @default.
- Q63405490 P8363 Q78089383 @default.
- Q63405490 P859 Q219563 @default.